Hjem › Ikke-småcellet lungekreft › Michigan › Canton
Kliniske studier for Ikke-småcellet lungekreft i Canton, MI
8 studier for Ikke-småcellet lungekreft søker deltakere på steder i og rundt Canton (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruttererFase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
RekruttererFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruttererFase 3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RekruttererFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruttererFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2/3
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruttererFase 2
- Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton
- Trinity Health Medical Center - Canton, Canton
Ikke-småcellet lungekreft-studier i andre byer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andre studier i Canton
- Lungekreft9 studier
- Prostatakreft8 studier
- Akut myelogen leukemi7 studier
- Kolorektal kreft6 studier
- Nyrekreft (nyrecellekarcinom)5 studier
- Eggstokkreft4 studier
- Blærekreft4 studier
- Brystkreft4 studier
- Spiserørkreft3 studier
- Mavekreft3 studier
- Pankreaskreft3 studier
- Tykktarmskreft3 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.